This podcast series focuses on providing Veterans Affairs clinicians with updates in the management of advanced melanoma, including consideration of anti-LAG-3 antibodies. It also provides an overview of the latest trials considering anti-LAG-3 antibodies for the management of advanced melanoma, and updates on immunotherapy approaches in clinical practice, including management of adverse events.

These podcasts are designed to help healthcare professionals assess the relationship between checkpoint inhibition and immunopathology in advanced melanoma, update them on the latest clinical data with anti-LAG3 antibody combinations in advanced melanoma, and provide strategies to optimize the safety of combination immunotherapy approaches in advanced melanoma. Additionally, healthcare professionals will be able to understand the importance of patient advocacy as we converse with a patient about their cancer diagnosis and treatment.